#United States #New York #Johnson & Johnson #IBD #Trellus Health

Trellus Health Partners with Pharmaceutical Company for Comprehensive Patient Support

Trellus Health plc, known for its innovative healthcare solutions, has recently announced an exciting partnership with Johnson & Johnson Health Care Systems Inc. This collaboration aims to launch a pilot program in the United States focused on supporting patients facing moderately to severely active inflammatory bowel disease (IBD). With the Trellus Elevate™ platform at its core, this initiative seeks to enhance the lives of patients grappling with these chronic conditions.

Transformative Digital Solutions

Trellus Elevate™ is not just a digital platform; it's a comprehensive solution that combines data analytics with personalized resilience programs. The objective is to empower patients to navigate the physical and emotional complexities of their health challenges. Through the integration of Trellus Elevate into Johnson & Johnson's Patient Support Programs (PSPs), eligible patients will gain essential tools and support to adhere to their treatment regimens effectively.

Dr. Marla Dubinsky, the CEO of Trellus Health, emphasized the significance of this partnership, stating, "We are thrilled to embark on our first substantial collaboration with the pharmaceutical sector, aligning with our strategic goals. By harnessing the power of Trellus Elevate, we aim to provide a seamless transition from clinical trials to patient support, ensuring overall success in managing chronic conditions."

Addressing the Complexity of IBD

IBD, which includes chronic conditions like Crohn's disease and ulcerative colitis, presents a multifaceted challenge for patients. The therapeutic ceiling has been reached with many existing treatments, making comprehensive support essential. The collaboration will focus on providing an all-encompassing care model that addresses both the emotional and physical aspects of managing IBD.

Dr. Dubinsky further stated, "Managing treatment regimens for lifelong, incurable immune disorders can be overwhelming. Our holistic approach aims to empower patients, helping them stay committed to their therapies while nurturing their overall well-being."

The traditional healthcare model often overlooks the emotional and mental health struggles that accompany chronic illnesses. By integrating psychological support with physical health strategies, Trellus Health aims to revolutionize patient care, ensuring individuals are not only surviving but thriving amidst their health challenges.

Clinical Proven Success

The Trellus Elevate™ program employs a scientifically backed, proprietary resilience methodology known as GRITT™. This approach has demonstrated notable improvements in patient outcomes, including a 71% reduction in emergency department visits and a 94% decrease in unplanned hospitalizations, underscoring the potential for significant cost savings for healthcare systems. Patients enrolled in the program reported a 49% reduction in opioid use and a 73% decrease in corticosteroid dependency within a year of joining the program.

This measurable success indicates a promising step toward redefining chronic illness management and offers potential applications across a broad range of chronic health conditions.

Looking Ahead

As this partnership unfolds, Trellus Health and Johnson & Johnson are poised to make a lasting impact on patient support in the healthcare landscape. Their collaborative efforts align with the growing trend of personalized medicine and value-based care, placing an emphasis on the whole individual rather than solely their medical conditions.

In conclusion, this partnership signifies a pivotal moment in the fight against chronic diseases like IBD. By prioritizing holistic care and leveraging innovative technology, Trellus Health and Johnson & Johnson are set to offer patients the hope and support they need to take control of their health journeys.

For more information on Trellus Health and its groundbreaking initiatives, visit Trellus Health Website.